All News
Filter News
Found 808,890 articles
-
Common Blood Test Identifies Benefits and Risks of Steroid Treatment in COVID-19 Patients
7/22/2020
Research from Albert Einstein College of Medicine and Montefiore Builds on Large British Study
-
Just - Evotec Biologics to Produce Monoclonal Antibody Products Against Covid-19 for the Department of Defense
7/22/2020
Evotec SE announced that the U.S. Department of Defense awarded its Seattle-based subsidiary, Just - Evotec Biologics, Inc. a contract valued up to $ 18.2 m to develop and manufacture monoclonal antibodies for treatment and/or prevention of COVID-19.
-
Winning Pharma Companies Encourage a Culture of ‘Compliant Collaboration’ Between Commerical and Medical Affairs Teams
7/22/2020
Only 39 Percent of Commercial Leaders Report a Strong to Very Strong Relationship with Medical Affairs Team, According to a New TGaS Landscape Report from Trinity Life Sciences
-
Ascentage Pharma Announces First Patient Dosed in the Phase Ib Study of MDM2-p53 Inhibitor APG-115 as Single Agent and in Combinations for the Treatment of Hematologic Malignancies in China
7/22/2020
Ascentage Pharma announced that the Phase Ib study of the company's novel MDM2-p53 inhibitor candidate APG-115 as a single agent or in combinations for the treatment of Chinese patients with relapsed/refractory acute myeloid leukemia, or relapsed/progressed high/very high risk myelodysplastic syndrome has dosed its first patient in China.
-
Invacare Corporation to Host Conference Call and Webcast to Discuss Second Quarter 2020 Financial Results
7/22/2020
Invacare Corporation announces that it will release its financial results for the second quarter ended June 30, 2020, after the market closes on Wednesday, August 5, 2020. The company will provide a live conference call and webcast to discuss these financial results on Thursday, August 6, 2020 at 8:30 AM ET.
-
Vystar Introduces RxAir400 UV-C Light Germicidal Air Purifier Extended Life UV Bulb, Wall Mount Option
7/22/2020
With heightened concern about protection from harmful airborne viruses, Vystar Corporation’s RxAir®400 Germicidal Ultraviolet light air purification systems offers new features and options that will make it easier to treat airborne pathogens wherever you go indoors.
-
Coala Life and My Cardiologist to roll-out the largest Real-Time Cardiac Monitoring program in Florida
7/22/2020
Remote Patient Monitoring program enabling long-term and real-time cardiac monitoring of patients in the safety of their homes
-
Toyoda Gosei Develops Deep UV LED Light Module for Sterilization
7/22/2020
Toyoda Gosei Co., Ltd. has developed a deep UV LED light module for use in the sterilization of water, air, and surfaces.
-
Anne B. Le Grand Joins Accuray Board of Directors
7/22/2020
Accuray Incorporated announced the appointment of Anne B. Le Grand to the company's Board of Directors, effective as of July 16, 2020. In addition, she will serve on the Board's Nominating and Corporate Governance Committee. With Ms. Le Grand's appointment, the Accuray Board will consist of nine members.
-
OraSure Technologies to Hold Second Quarter 2020 Earnings Conference Call on August 5th, 2020
7/22/2020
OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2020 second quarter financial results and certain business developments for 5:00 pm ET on Wednesday, August 5, 2020.
-
OneClick.chat Awarded Additional $1.8 Million in Prestigious Grant Funding from NIH
7/22/2020
Startup to Continue Research with University of Illinois Urbana-Champaign into How Video Chat Technology Can Help Aging Adults
-
Chugai and Biofourmis Partner to Develop an Objective Assessment of Pain Using Digital Technology
7/22/2020
- Chugai and Biofourmis are partnering to develop a digital solution leveraging Biofourmis' Biovitals® platform for pain management in patients with endometriosis - A non-interventional study will be conducted with endometriosis patients to validate the novel tool in real-life conditions
-
Option Care Health Announces Pricing of Offering of 18,000,000 Shares of Common Stock - July 22, 2020
7/22/2020
Option Care Health, Inc. announced the pricing of an underwritten offering of 18,000,000 shares of its common stock, which includes 10,000,000 shares offered by the Company and 8,000,000 shares offered by an affiliate of Madison Dearborn Partners, at a price to the public of $12.50 per share. The Selling Stockholder has granted the underwriters a 30-day option to purchase up to 2,700,000 additional shares of common stock.
-
Syapse Highlights Real-World Evidence Related to COVID-19 and Cancer at AACR Virtual Meeting
7/22/2020
Syapse®, a real-world data company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, announced results based on real-world data that were highlighted at the AACR Virtual Meeting on COVID-19 and Cancer.
-
Illinois Gastroenterology Institute (IGI) Joins GI Alliance
7/22/2020
GI Alliance, the nation's largest independent gastroenterology services organization, announced further expansion in the Midwest and Illinois through a partnership with Illinois Gastroenterology Institute.
-
New COVID-19 Projections Show Risk for Resurgence Continues Spread to Northeast
7/22/2020
Updated COVID-19 projections released by PolicyLab at Children's Hospital of Philadelphia show communities across the Northeast are struggling to fend off risk for virus resurgence as the south continues to experience significant growth in cases.
-
Coronavirus (COVID-19) Update: Daily Roundup - July 22, 2020
7/22/2020
The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic:.
-
LHC Group announces second quarter 2020 earnings release and conference call dates
7/22/2020
LHC Group, Inc . (NASDAQ: LHCG) today announced details for the release of its results for the second quarter ended June 30, 2020. LHC Group plans to issue its earnings release after the market closes on Wednesday, August 5, 2020, and will host a conference call on Thursday, August 6, 2020, at 10:00 a.m. Eastern time. The toll-free number to call for this interactive teleconference is (866) 393-1608 (international callers: (973) 890-8327).
-
miRagen to Report Second Quarter 2020 Financial Results on August 5, 2020
7/22/2020
miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced it will report its second quarter 2020 financial results after the financial markets close on Wednesday August 5, 2020. The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Wednesday August 5, 2020. To access the call, please d
-
Zhittya Genesis Medicine, Inc. Announces a Zoom Webinar“Parkinson’s Disease: Therapeutic Angiogenesis as a Disease Modifying, Breakthrough Therapy?”
7/22/2020
Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Zoom Webinar on its potential breakthrough therapy to reverse the progression of Parkinson’s disease. Currently, no therapies on the market can halt or reverse this disorder. The webinar will be broadcasted on Monday August 3, 2020 at 1:00 PM Pacific time (4:00 PM Eastern). The webinar is available to all interested parties, free of charge. Zhittya is advanci